Bactobilia after liver transplantation: Frequency and antibiotic susceptibility

Liver Transplantation

Volumn 12, Issue 5, 2006, Pages 747-753

  Millonig, Gunda ^a   Buratti, Thomas ^a   Graziadei, Ivo W ^a   Schwaighofer, Hubert ^b   Orth, Dorothea ^b   Margreiter, Raimund ^b   Vogel, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CYCLOSPORIN A; GENTAMICIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RAPAMYCIN; STEROID; TACROLIMUS; VANCOMYCIN;

ADULT; AGED; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BACTOBILIA; CHOLANGITIS; CHOLESTASIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FUNGUS ISOLATION; GALLSTONE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SINGLE DRUG DOSE; STENT; VATER PAPILLOTOMY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIA; BILE; CHOLANGIOGRAPHY; CHOLANGITIS; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 33646449950     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20711     Document Type: Article

References (30)

1. Sung JY, Costerton JW, Shaffer EA. Defense system in the biliary tract against bacterial infection. Dig Dis Sci 1992; 37:689-696.
2. Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 1991;101:1374-1381.
3. Kiesslich R, Holfelder M, Will D, Hahn M, Nafe B, Genitsariotis R, et al. Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance [in German]. Z Gastroenterol 2001;39: 985-992.
4. Csendes A, Becerra M, Burdiles P, Demian I, Bancalari K, Csendes P. Bacteriological studies of bile from the gallbladder in patients with carcinoma of the gallbladder, cholelithiasis, common bile duct stones and no gallstones disease. Eur J Surg 1994;160:363-367.
5. Ohdan H, Oshiro H, Yamamoto Y, Tanaka I, Inagaki K, Sumimoto K, et al. Bacteriological investigation of bile in patients with cholelithiasis. Surg Today 1993;23:390-395.
6. Leung JW, Sung JY, Costerton JW. Bacteriological and electron microscopy examination of brown pigment stones. J Clin Microbiol 1989;27:915-921.
7. Sung JY, Leung JW, Olson ME, Lundberg MS, Costerton JW. Demonstration of transient bacterobilia by foreign body implantation in feline biliary tract. Dig Dis Sci 1991; 36:943-948.
8. Patkowski W, Nyckowski P, Zieniewicz K, Pawlak J, Michalowicz B, Kotulski M, et al. Biliary tract complications following liver transplantation. Transplant Proc 2003; 35: 2316-2317.
9. Johnston TD, Gates R, Reddy KS, Nickl NJ, Ranjan D. Nonoperative management of bile leaks following liver transplantation. Clin Transplant 2000;14(4 Pt 2):365-369.
10. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Wahlstrom HE, Moore SB, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992;16:49-53.
11. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Buckel EG, Steers JL, et al. Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology 1993;17:605-609.
12. Anforderungen der Hygiene an die baulch-funktionelle bestaltung und Apparative Ausstattung von Endoskopieeinheiten last. Available at: http://www.rki.de. Accessed February 16, 2006.
13. Swidsinski A, Schlien P, Pernthaler A, Gottschalk U, Barlehner E, Decker G, et al. Bacterial biofilm within diseased pancreatic and biliary tracts. Gut 2005;54:388-395.
14. Nomura T, Shirai Y, Hatakeyama K. Enterococcal bactibilia in patients with malignant biliary obstruction. Dig Dis Sci 2000;45:2183-2186.
15. Bjornsson ES, Kilander AF, Olsson RG. Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis - a study of bile cultures from ERCP. Hepatogastroenterology 2000;47:1504-1508.
16. Neve R, Biswas S, Dhir V, Mohandas KM, Kelkar R, Shukla P, et al. Bile cultures and sensitivity patterns in malignant obstructive jaundice. Indian J Gastroenterol 2003;22:16-18.
17. Rosch T, Triptrap A, Born P, Ott R, Weigert N, Frimberger E, et al. Bacteriobilia in percutaneous transhepatic biliary drainage: occurrence over time and clinical sequelae. A prospective observational study. Scand J Gastroenterol 2003;38:1162-1168.
18. Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 2002;56:885-889.
19. Byl B, Deviere J, Struelens MJ, Roucloux I, De Coninck A, Thys JP, et al. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study. Clin Infect Dis 1995;20:1236-1240.
20. Niederau C, Pohlmann U, Lubke H, Thomas L. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc 1994;40:533-537.
21. Gilbert DN, Moellering Robert C., Sande Merle A. The Sanford Guide to Antimicrobial Therapy 2002. Hyde Park: Antimicrobial Therapy Inc., 2002.
22. Chen CY, Shiesh SC, Wu MC, Lin XZ. The effects of bile duct obstruction on the biliary secretion of ciprofloxacin in piglets. Am J Gastroenterol 1999;94:2408-2411.
23. Parry MF, Smego DA, Digiovanni MA. Hepatobiliary kinetics and excretion of ciprofloxacin. Antimicrob Agents Chemother 1988;32:982-985.
24. van den Hazel SJ, de Vries XH, Speelman P, Dankert J, Tytgat GN, Huibregtse K, et al. Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract. Antimicrob Agents Chemother 1996;40:2658-2660.
25. Maudgal DP, Maxwell JD, Lees IJ, Wild RN. Biliary excretion of amoxycillin and ceftriaxone after intravenous administration in man. Br J Clin Pharmacol 1982;14:213-217.
26. Park HZ, Lee SP, Schy AL. Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology 1991;1006:1665-1670.
27. Graziani AL, Gibson GA, MacGregor RR. Biliary excretion of imipenem-cilastatin in hospitalized patients. Antimicrob Agents Chemother 1987; 31(11):1718-1721.
28. Leung JW, Chan CY, Lai CW, Ko TC, Cheng AF, French GL. Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin. Antimicrob Agents Chemother 1992; 36:2057-2060.
29. Currie BP, Lemos-Filho L. Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin resistant enterococci. Antimicrob Agents Chemother 2004;48:4427-4429.
30. Reckziegel R, Maguilnik I, Goldani LZ. Gentamicin concentration in bile after once-daily versus thrice-daily dosing of 4 mg/kg/day. J Antimicrob Chemother 2001;48: 327-329.